Autoren

Chris Thornham

Partner

Read More

Laurence Lieberman

Partner

Read More

Colin McCall

Partner

Read More
Autoren

Chris Thornham

Partner

Read More

Laurence Lieberman

Partner

Read More

Colin McCall

Partner

Read More

29. September 2019 |

Arbitration considerations for life science companies

In the second instalment of our life sciences disputes webinar series – we provided practical tips and advice, discussed key legislation and shared case studies on how life sciences organisations can mitigate and manage their litigation risk, including:

  • What subject-matter can be arbitrated and how arbitration may arise.
  • Typical advantages / disadvantages of arbitration versus litigation.
  • Industry–specific points for parties in the life sciences considering arbitration.
  • Arbitration proceedings rules, tribunal composition, location and choice of law.
  • Decisions, remedies, enforcement and challenges.


View the first webinar in our series: Managing cybersecurity risk from a life sciences perspective


Call To Action Arrow Image

Newsletter-Anmeldung

Wählen Sie aus unserem Angebot Ihre Interessen aus!

Jetzt abonnieren
Jetzt abonnieren

Related Insights

Life Sciences & Healthcare

Termination, force majeure and frustration – international perspectives on the life sciences sector

17. April 2020
QUICK READ

von mehreren Autoren

Klicken Sie hier für Details

Events

Alle Veranstaltungen und Webinare finden Sie auf unserer Event-Seite.